Search

Search Constraints

You searched for: Author/Creator Julsgaard, M

Search Results

1. DOP29 Pregnancy outcomes in IBD patients treated with vedolizumab, anti-TNF, or conventional therapy. (25th January 2019)

2. Long‐Term Safety ofIn UteroExposure to Anti‐TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study. (March 2018)

3. P252 Solid organ transplant (with the exception of liver) in patients with inflammatory bowel disease: An ECCO CONFER Multicentre Case Series. (30th January 2023)

4. P347 Practical recommendations for the collection of the patient-reported outcomes included in the Health Outcomes Observatory (H2O) core data set for patients with inflammatory bowel disease. (30th January 2023)

5. P487 Surgery due to inflammatory bowel disease during pregnancy: mothers and offspring outcomes (SCAR Study). (21st January 2022)

6. P674 Ustekinumab is the preferred biological agent in IBD patients with hidradenitis suppurativa failing anti-TNF therapy : results from a real-life multicenter cohort. (30th January 2023)

7. P778 Effectiveness and safety of a second-line rescue therapy for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study). (30th January 2023)